Interview with Jiny Kim and Pasha Sateri at IMCAS, Paris, 2025. Jiny Kim, Vice President
of Solta Medical. Pasha Sateri, Vice President for Strategic Marketing
ANTI-AGE Magazine: How does Solta Medical integrate a regenerative and personalised approach to aesthetic procedures?
Pasha Sateri: Our treatments go beyond addressing visible signs of aging; they enhance skin structure and vitality by stimulating natural regeneration mechanisms. This approach delivers progressive and long-lasting results while ensuring a natural appearance. By combining technological innovation with an understanding of biological processes, Solta Medical offers solutions that not only enhance beauty but also improve skin health over time.
AAM: How do you adapt your protocols to patients’ needs?
Pasha Sateri: Personalisation is at the heart of our approach. Our devices, such as Thermage® and Fraxel®, allow precise adjustments based on each patient’s specific requirements. Thermage® optimises skin tightening by adapting the intensity of radiofrequency waves, while Fraxel® addresses various skin concerns such as fine lines, pigmentation, and scars by modifying the depth and intensity of the laser. This flexibility ensures optimal results without the risks of over or under-treatment.
AAM: What impact do new technologies have on the patient experience?
Pasha Sateri: Artificial intelligence and digital tools are revolutionising the aesthetic medicine experience. These advancements enable precise skin analysis and personalised treatment protocols. Such technologies help practitioners optimise decisions, enhance procedure safety, and deliver more consistent and predictable results. This approach also improves communication between doctors and patients, providing them with a clear visualisation of expected outcomes.
AAM: How does Solta Medical integrate well-being into its treatments?
Jiny Kim: Aesthetics is not just about appearance; it plays a vital role in overall well-being. We prioritise non-invasive solutions that stimulate the skin’s natural mechanisms, fostering gradual and harmonious improvements. Thermage® boosts collagen production for long-lasting skin firmness, while Fraxel® and Clear & Brilliant® enhance skin texture and radiance. Our treatments aim not only to enhance beauty but also to boost self-confidence and overall well-being.
AAM: What are the main challenges in the aesthetic market?
Jiny Kim: The aesthetic medicine industry is constantly evolving, with strong competition and increasing patient expectations. To stay ahead, we focus on three key areas:
• Innovation: We continuously invest in R&D to develop advanced, safe, and high-performance technologies in collaboration with medical experts.
• Market adaptation: Each country has its own aesthetic expectations and regulatory requirements. We strive to understand these nuances to offer tailored solutions for each market.
• Clinical excellence: Providing effective and proven treatments is our priority. We ensure our technologies deliver optimal results while guaranteeing patient safety and satisfaction.
AAM: What does the future hold for Solta Medical?
Jiny Kim: We will continue to innovate and refine our treatments to meet the growing needs of patients and practitioners. By combining personalisation, effectiveness, and well-being, we are committed to shaping the future of aesthetic medicine while remaining a leader in the field.
